What is the ADAP stock price prediction for next 2 weeks?

According to our price prediction algorithm,Adaptimmune Therapeutics plc (ADAP) price will be around $0.06 in the next 2 weeks. This means it will increase by 29.48453608247421 from the last closing price. This prediction may vary from other time period filters for ADAP stock.

What can be the highest Possible price of ADAP stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, ADAP can achieve the highest price of $0.12 which is 146.8653710820507 higher than last closing price. This prediction may vary from other time period filters for ADAP stock.

What can be the lowest Possible price of ADAP stock in next 2 weeks?

As per the forecast and algorithmic analysis, ADAP stock price can be as low as $0.00 which is -89.737755977153 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for ADAP stock.

Will ADAP stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that ADAP stock will gain29.48453608247421 in the next 2 weeks. This prediction may vary from other time period filters for ADAP stock.

What is ADAP stock last closing price?

Last closing price of ADAP stock was $0.05.

What is ADAP stock price prediction?

ADAP stock price prediction means predicting the future closing prices of ADAP stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of ADAP stock in a certain time period.

How we predict ADAP stock future prices?

If you are searching for ADAP stock forecast, analysis or price prediction, then you might be wondering what Adaptimmune Therapeutics plc (ADAP) will do in the future. Our ADAP price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This ADAP price prediction will likely answer most of your questions.

How frequent we update ADAP stock predictions?

We are updating the forecasts for the ADAP stock on daily basis.

Is using ML forecasting for ADAP stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for ADAP stock same for all the time periods?

No, the prediction for ADAP stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Adaptimmune Therapeutics plc Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$0.050%Since 2 Weeks

Predicted Price$0.0629.48%For 2 Weeks

Upper Predicted Price$0.12146.87%For 2 Weeks

Lower Predicted Price$0.00-89.74%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of ADAP will rise by +29.48% over the next 2 Weeks and hit $0.06 by Monday, November 10, 2025. In that time frame, ADAP's share price is expected to range between $0.00 and $0.12.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Nov 10, 2025	0.07	0.13	0.19
Nov 7, 2025	0.10	0.16	0.22
Nov 6, 2025	0.09	0.16	0.22
Nov 5, 2025	0.08	0.14	0.21
Nov 4, 2025	0.07	0.13	0.19
Nov 3, 2025	0.06	0.12	0.18
Oct 31, 2025	0.09	0.15	0.21
Oct 30, 2025	0.09	0.15	0.22
Oct 29, 2025	0.08	0.14	0.21
Oct 28, 2025	0.06	0.13	0.19

ADAP shares fell -3.00% in Friday, November 21, 2025's trading session, dropping from a previous close of $0.05 to move at $0.05. The stock demonstrated notable intraday movement (see ADAP's key stats for a full breakdown), fluctuating between $0.04 and $0.06, a +40.94% trading range. While recent weeks have seen some volatility, ADAP has managed to secure a -69.69% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 48.74M shares changing hands, 3.4M more than the previous session. This amounted to $2.36M in total market activity.

Will ADAP Continue Its Upward Trend?

According to analyst ratings and projections for ADAP, Adaptimmune Therapeutics plc shares are anticipated to increase by +74.65%, potentially reaching $0.19 per share by November 10, 2025. Short-term technical indicators currently suggest a bullish sentiment for ADAP. However, the stock has recorded 17 negative trading days within the past 30 sessions. Based on the ADAP stock forecast, now is a good time to buy ADAP stock because its current trading price is -61.48% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on ADAP covering social and institutional perspectives.

ADAP Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into ADAP's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 35.03% to 41.73%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 43.09%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 43.06%, maintains a neutral outlook for the long term. Insights into ADAP's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Adaptimmune Therapeutics Short-Term Forecasts

ADAP Forecast For Next 5 Days

Our algorithm anticipates Adaptimmune Therapeutics (ADAP) stock could hit $0.11 by Nov 21, 2025. This represents a +134.02% fall from today's price, following a -6.95% change over the past five days.

ADAP Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Adaptimmune Therapeutics plc (ADAP) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $0.09, which would mean a +85.57% increase from the current price of $0.05. Projections for this period range from a high of $0.17 to a low of $0.00.

ADAP Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Adaptimmune Therapeutics's price over the next three months point to a rise. ADAP stock is expected to peak at $0.48 on Mar 04, 2026 before potentially dipping to $0.03 on Jun 04, 2026. On average, ADAP is likely to trade around $0.27 in the coming 90 days.

Adaptimmune Therapeutics Stock Forecast 2025

Based on our predictive models, Adaptimmune Therapeutics (ADAP) is expected to trade between $0.00 and $0.53 throughout 2026. This would result in an average price of $0.22, potentially offering investors a +353.61% return from current levels.

Adaptimmune Therapeutics plc Monthly Forecast 2025–2026

November 2025

According to our latest forecast models, Adaptimmune Therapeutics plc (ADAP) is positioned to show a strong performance in November 2025. The price is predicted to move between $0.56 and $0.82, settling at an average of $0.71. This could translate to a +1,363.92% gain.

December 2025

Based on current market signals, Adaptimmune Therapeutics plc is projected to trend december 2025. We forecast a trading range from $0.35 to $0.56, with a likely average price of $0.44. Investors could expect a potential return of +807.22%.

January 2026

Our predictive algorithms indicate Adaptimmune Therapeutics plc stock may see a shift in January 2026. The expected range spans $0.30–$0.53, with an average target of $0.44. This represents a positive outlook and a possible gain of +807.22%.

February 2026

Analyzing established trends, Adaptimmune Therapeutics plc looks set to move in February 2026. Projections place the stock between $0.25 and $0.49, averaging around $0.37. This suggests a +662.89% gain from current levels.

March 2026

Market indicators suggest Adaptimmune Therapeutics plc could experience notable changes during March 2026. Prices could fluctuate within $0.21 to $0.49, with a midpoint forecast of $0.40. The stock might deliver a +724.74% gain.

April 2026

Forecasting for April 2026, models estimate that Adaptimmune Therapeutics plc may undergo key fluctuations. If trends hold, the stock might trade between $0.09 and $0.32, averaging $0.23. This signals a positive trajectory with potential returns around +374.23%.

May 2026

According to our latest forecast models, Adaptimmune Therapeutics plc (ADAP) is positioned to show a strong performance in May 2026. The price is predicted to move between $0.04 and $0.19, settling at an average of $0.20. This could translate to a +312.37% gain.

June 2026

Based on current market signals, Adaptimmune Therapeutics plc is projected to trend june 2026. We forecast a trading range from $0.00 to $0.15, with a likely average price of $0.15. Investors could expect a potential return of +209.28%.

July 2026

Our predictive algorithms indicate Adaptimmune Therapeutics plc stock may see a shift in July 2026. The expected range spans $0.00–$0.08, with an average target of $0.12. This represents a positive outlook and a possible gain of +147.42%.

August 2026

Analyzing established trends, Adaptimmune Therapeutics plc looks set to move in August 2026. Projections place the stock between $0.00 and $0.01, averaging around $0.14. This suggests a +188.66% gain from current levels.

September 2026

Market indicators suggest Adaptimmune Therapeutics plc could experience notable changes during September 2026. Prices could fluctuate within $0.00 to $0.00, with a midpoint forecast of $0.08. The stock might deliver a +64.95% gain.

October 2026

Forecasting for October 2026, models estimate that Adaptimmune Therapeutics plc may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $0.06. This signals a positive trajectory with potential returns around +23.71%.

ADAP's history of dividends and stock splits also plays a role in long-term investor confidence.